予測遺伝子検査&消費者/ウェルネスゲノミクスの世界市場:予測検査、消費者ゲノミクス、ウェルネス遺伝学

◆英語タイトル:Predictive Genetic Testing & Consumer/Wellness Genomics Market Size, Share & Trends Analysis Report By Test Type (Population Screening, Susceptibility), By Application, By Setting Type, And Segment Forecasts, 2019 - 2025
◆商品コード:GV9NV108
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2019年6月
◆ページ数:220
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥642,600見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥750,600見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥966,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

当調査レポートでは、予測遺伝子検査&消費者/ウェルネスゲノミクスの世界市場について調査・分析し、市場動向、検査種類別(予測検査、消費者ゲノミクス、ウェルネス遺伝学)分析、用途別(乳がんおよび卵巣がんのスクリーニング、心臓血管のスクリーニング、糖尿病のスクリーニングおよびモニタリング、結腸がんのスクリーニング、パーキンソニズム/アルツハイマー病、泌尿器科スクリーニング/前立腺がん、整形外科および筋骨格のスクリーニング、その他のがんのスクリーニング、その他の疾患のスクリーニング)分析、設定タイプ別(DTC、プロ)分析、地域別分析、競合動向などを含め次の構成でお届け致します。

・調査手法及び範囲
・エグゼクティブサマリー
・市場動向
・予測遺伝子検査&消費者/ウェルネスゲノミクスの世界市場:検査種類別(予測検査、消費者ゲノミクス、ウェルネス遺伝学)
・予測遺伝子検査&消費者/ウェルネスゲノミクスの世界市場:用途別(乳がんおよび卵巣がんのスクリーニング、心臓血管のスクリーニング、糖尿病のスクリーニングおよびモニタリング、結腸がんのスクリーニング、パーキンソニズム/アルツハイマー病、泌尿器科スクリーニング/前立腺がん、整形外科および筋骨格のスクリーニング、その他のがんのスクリーニング、その他の疾患のスクリーニング)
・予測遺伝子検査&消費者/ウェルネスゲノミクスの世界市場:設定タイプ別(DTC、プロ)
・予測遺伝子検査&消費者/ウェルネスゲノミクスの世界市場:地域別
・競合動向
【レポートの概要】

The global predictive genetic testing & consumer/wellness genomics market size is expected to reach USD 8.5 billion by 2025, registering a CAGR of 13.9% over the forecast period, according to a new report by Grand View Research, Inc. Factors influencing the market progression include growing awareness about utilization of genetic tests that aid in prediction of gene susceptibility to disease development prior to symptoms. Moreover, rise in sales of these products owing to growing inclination of physicians is driving the market.

Introduction of novel platforms in next-generation sequencing technology aids in enhancing the accuracy of predictive genetic and consumer genomics kits. Market participants are engaged in implementing novel protocols to launch products that require minimal technical assistance and provide optimal customer satisfaction.

Pharmaceutical firms are engaged in several agreement models with genomic vendors for the release of novel therapeutics based on patient’s phenotypic and genotypic information. For instance, in July 2018, GlaxoSmithKline plc purchased 23andMe’s customer data to develop a new drug, thus promoting patient-centered healthcare.

Further key findings from the study suggest:

• High adoption rate of these products in clinical practice for detection of disease susceptibility resulted in the largest share of this segment in 2018

• Growing awareness related to direct to consumer (DTC) genetic tests and entry of new players is attributive to the fastest growth of the consumer genomics segment

• Genetic susceptibility tests are of great interest in gynecology and endocrinology-related research and diagnosis, thus allowing it to capture the maximum revenue share. These tests enable the identification of susceptible genes or mutations in adenomyosis, endometriosis, and postmenopausal osteoporosis

• Application of predictive genetic and consumer genomics is highest in the detection of breast and ovarian cancer as these tests hold the potential to identify BRCA mutations in patients

• Advent of predictive tests for identification of MLH1, MSH2 genes for colorectal cancer diagnosis is expected to fuel market growth in the coming years

• Colorectal screening initiatives such as mass screening and population-based screening are expected to boost segment growth

• North America dominated the market with the largest revenue share in 2018 owing to the presence of major players and high adoption rate

• Asia Pacific is expected to witness substantial growth in the coming years owing to increasing adoption of these products in developing economies

• Manufacturers contributing significantly to market growth include Pathway Genomics; ARUP Laboratories; BGI; Illumina, Inc.; 23andMe, Inc.; Color Genomics Inc.; and Myriad Genetics, Inc. Established as well as emerging companies are involved in adopting strategic moves for the launch of novel products.

【レポートの目次】

Table of Contents

Chapter 1 Research Methodology
1.1 Market Segmentation & Scope
1.2 Market Definition
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Data Visualization
1.6 Data Validation & Publishing
Chapter 2 Executive Summary
2.1 Consumer/Wellness Genomics Market Outlook, 2014 – 2025
2.2 Consumer/Wellness Genomics Market : Segment Outlook, 2014 – 2025
2.3 Consumer/Wellness Genomics Market : Competitive Insights
Chapter 3 Predictive Genetic Testing & Consumer/Wellness Genomics Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2 Penetration & Growth Prospect Mapping, 2018
3.3 Product Pipeline Analysis, by Stage
3.4 Cost Structure Analysis
3.5 User Perspective Analysis
3.5.1. Consumer behavior analysis
3.5.2. Market influencer analysis
3.6 Procedure Cost Analysis/Breakdown
3.7 List of Key End-users By Region, By Test Type, By Application, By Country
3.8 Technology Overview
3.8.1. Technology timeline
3.9 Regulatory Framework
3.9.1. Standards & compliances
3.10 Predictive Genetic Testing & Consumer/Wellness Genomics Market – Market Dynamics
3.10.1 Market driver analysis
3.10.1.1 Rise in number of novel partnership models
3.10.1.2 Introduction of fragmented point-solutions across the genomics value chain
3.10.1.3 Exponentially decreasing costs for genetic sequencing
3.10.1.4 Introduction of technological advancements in cloud computing and data integration
3.10.2 Market restraint analysis
3.10.2.1 Absence of well-defined regulatory framework and low adoption rate
3.10.2.2 Ethical concerns pertaining to implementation
3.10.3 Market challenges analysis
3.10.3.1 Defects observed in consumer genetic kits challenges the market growth
3.11 Predictive Genetic Testing & Consumer/Wellness Genomics Market Analysis Tools
3.11.1 Industry Analysis – Porter’s
3.11.1.1 Supplier power : Less complex nature of genetic tests result in Low bargaining supplier power
3.11.1.2 Buyer power: Low bargaining buyer power due to limited predictive gentic tests approval
3.11.1.3 Substitution threat: Low threat of substitution due to stringent regulations
3.11.1.4 New entrants threat: High capital investments results in low new entrant threat
3.11.1.5 Competitive rivalry: Cost effective solutions by key players results in high competitive rivalry
3.11.2 PESTEL analysis
3.11.2.1 Political landscape
3.11.2.2 Environmental landscape
3.11.2.3 Social landscape
3.11.2.4 Technology landscape
3.11.2.5 Legal landscape
3.11.3 Major deals & strategic alliances analysis
3.11.3.1 Joint ventures
3.11.3.2 Mergers & acquisitions
3.11.3.3 Licensing & partnership
3.11.3.4 Technology collaborations
3.11.3.5 Strategic divestments
3.11.4 Market entry strategies
3.11.5 Case studies
Chapter 4 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company/Competition Categorization
4.3 Vendor Landscape
4.3.1 List of key distributors and channel partners
4.3.2 Key customers
4.3.3 Key company market share analysis, 2018
4.4 Public Companies
4.4.1 Company market position analysis
4.4.2 Company market share/ranking by region
4.4.3 Competitive dashboard analysis
4.4.4 Market differentiators
4.4.5 Synergy analysis: Major deals & strategic alliances
4.5 Private Companies
4.5.1 List of key emerging companies
4.5.2 Funding outlook
4.5.3 Regional network map
4.5.4 Company market position analysis
4.5.5 Supplier Ranking
Chapter 5 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Test Type Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 Test Type Market Share Analysis, 2018 & 2025
5.3 Market: Test Type Movement Analysis, 2018 & 2025
5.4 Market, by Test Type, 2014 to 2025
5.5 Market Size & Forecasts and Trend Analyses, 2014 to 2025 for the following,
5.5.1 Predictive testing
5.5.1.1 Global predictive testing market, 2014 – 2025 (USD Million)
5.5.1.2 Genetic susceptibility test
5.5.1.2.1 Global genetic susceptibility test market, 2014 – 2025 (USD Million)
5.5.1.3 Predictive diagnostics
5.5.1.3.1 Global predictive diagnostics test market, 2014 – 2025 (USD Million)
5.5.1.4 Population screening programs
5.5.1.4.1 Global population screening programs market, 2014 – 2025 (USD Million)
5.5.2 Consumer genomics
5.5.2.1 Global consumer genomics market, 2014 – 2025 (USD Million)
5.5.3 Wellness genetics
5.5.3.1 Global wellness genetics market, 2014 – 2025 (USD Million)
5.5.3.2 Nutria genetics
5.5.3.2.1 Global nutria genetics market, 2014 – 2025 (USD Million)
5.5.3.3 Skin & Metabolism Genetics
5.5.3.3.1 Global skin & metabolism genetics market, 2014 – 2025 (USD Million)
5.5.3.4 Others
5.5.3.4.1 Global other tests market, 2014 – 2025 (USD Million)
5.6 Predictive Genetic Testing & Consumer/Wellness Genomics Test Type Market, by Application, 2014 to 2025
Chapter 6 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Application Estimates & Trend Analysis
6.1. Definitions & Scope
6.2. Application Market Share Analysis, 2018 & 2025
6.3 Market: Application Movement Analysis, 2018 & 2025
6.4. Market, by Application, 2014 to 2025
6.5 Market Size & Forecasts and Trend Analyses, 2014 to 2025 for the following,
6.5.1 Breast & ovarian cancer screening
6.5.1.1 Global breast & ovarian cancer screening market, 2014 – 2025 (USD Million)
6.5.2 Cardiovascular screening
6.5.2.1 Global cardiovascular screening market, 2014 – 2025 (USD Million)
6.5.3 Diabetic screening & monitoring
6.5.3.1 Global diabetic screening & monitoring market, 2014 – 2025 (USD Million)
6.5.4 Colon cancer screening
6.5.4.1 Global colon cancer screening market, 2014 – 2025 (USD Million)
6.5.5 Parkinsonism / Alzheimer’s disease
6.5.5.1 Global Parkinsonism / Alzheimer’s disease market, 2014 – 2025 (USD Million)
6.5.6 Urologic Screening/ Prostate Cancer Screening
6.5.6.1 Global urologic screening/ prostate cancer screening market, 2014 – 2025 (USD Million)
6.5.7 Orthopedic & musculoskeletal screening
6.5.7.1 Global orthopedic & musculoskeletal screening market, 2014 – 2025 (USD Million)
6.5.8 Other cancer screening
6.5.8.1 Global other cancer screening market, 2014 – 2025 (USD Million)
6.5.9 Other diseases screening
6.5.9.1 Global other diseases screening market, 2014 – 2025 (USD Million)
Chapter 7 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Setting Type Estimates & Trend Analysis
7.1. Definitions & Scope
7.2. Setting Type Market Share Analysis, 2018 & 2025
7.3 Market: Setting Type Movement Analysis, 2018 & 2025
7.4. Market, by Setting Type, 2014 to 2025
7.5 Market Size & Forecasts and Trend Analyses, 2014 to 2025 for the following,
7.5.1 DTC
7.5.1.1 Market for DTC settings, 2014 – 2025 (USD Million)
7.5.2 Professional
7.5.2.1 Market professional settings, 2014 – 2025 (USD Million)
Chapter 8 Predictive Genetic Testing & Consumer/Wellness Genomics Market: Regional Estimates & Trend Analysis, by Test Type, Application & Setting Type
8.1 Market Share by Region, 2018 & 2025
8.2 Regional Market Share and Leading Players, 2018
8.2.1 North America
8.2.2 Europe
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East & Africa
8.3 North America
8.3.1 Consumer/wellness genomics market, 2014 – 2025 (USD Million)
8.3.2 U.S.
8.3.2.1 Consumer/wellness genomics market, by test type, 2014 – 2025 (USD Million)
8.3.2.2 Consumer/wellness genomics market, by application, 2014 – 2025 (USD Million)
8.3.2.3 Consumer/wellness genomics market, by setting type, 2014 – 2025 (USD Million)
8.3.3 Canada
8.3.3.1 Consumer/wellness genomics market, by test type, 2014 – 2025 (USD Million)
8.3.3.2 Consumer/wellness genomics market, by application, 2014 – 2025 (USD Million)
8.3.3.3 Consumer/wellness genomics market, by setting type, 2014 – 2025 (USD Million)
8.4 Europe
8.4.1 Consumer/wellness genomics market, 2014 – 2025 (USD Million)
8.4.2 Germany
8.4.2.1 Consumer/wellness genomics market, by test type, 2014 – 2025 (USD Million)
8.4.2.2 Consumer/wellness genomics market, by application, 2014 – 2025 (USD Million)
8.4.2.3 Consumer/wellness genomics market, by setting type, 2014 – 2025 (USD Million)
8.4.3 U.K.
8.4.3.1 Consumer/wellness genomics market, by test type, 2014 – 2025 (USD Million)
8.4.3.2 Consumer/wellness genomics market, by application, 2014 – 2025 (USD Million)
8.4.3.3 Consumer/wellness genomics market, by setting type, 2014 – 2025 (USD Million)
8.5 Asia Pacific
8.5.1 Consumer/wellness genomics market, 2014 – 2025 (USD Million)
8.5.2 Japan
8.5.2.1 Consumer/wellness genomics market, by test type, 2014 – 2025 (USD Million)
8.5.2.2 Consumer/wellness genomics market, by application, 2014 – 2025 (USD Million)
8.5.2.3 Consumer/wellness genomics market, by setting type, 2014 – 2025 (USD Million)
8.5.3 China
8.5.3.1 Consumer/wellness genomics market, by test type, 2014 – 2025 (USD Million)
8.5.3.2 Consumer/wellness genomics market, by application, 2014 – 2025 (USD Million)
8.5.3.3 Consumer/wellness genomics market, by setting type, 2014 – 2025 (USD Million)
8.5.4 Australia
8.5.4.1 Consumer/wellness genomics market, by test type, 2014 – 2025 (USD Million)
8.5.4.2 Consumer/wellness genomics market, by application, 2014 – 2025 (USD Million)
8.5.4.3 Consumer/wellness genomics market, by setting type, 2014 – 2025 (USD Million)
8.5.5 India
8.5.5.1 Consumer/wellness genomics market, by test type, 2014 – 2025 (USD Million)
8.5.5.2 Consumer/wellness genomics market, by application, 2014 – 2025 (USD Million)
8.5.5.3 Consumer/wellness genomics market, by setting type, 2014 – 2025 (USD Million)
8.5.6 Singapore
8.5.6.1 Consumer/wellness genomics market, by test type, 2014 – 2025 (USD Million)
8.5.6.2 Consumer/wellness genomics market, by application, 2014 – 2025 (USD Million)
8.5.6.3 Consumer/wellness genomics market, by setting type, 2014 – 2025 (USD Million)
8.6 Latin America
8.6.1 Consumer/wellness genomics market, 2014 – 2025 (USD Million)
8.6.2 Brazil
8.6.2.1 Consumer/wellness genomics market, by test type, 2014 – 2025 (USD Million)
8.6.2.2 Consumer/wellness genomics market, by application, 2014 – 2025 (USD Million)
8.6.2.3 Consumer/wellness genomics market, by setting type, 2014 – 2025 (USD Million)
8.7 MEA
8.7.1 Consumer/wellness genomics market, 2014 – 2025 (USD Million)
8.7.2 South Africa
8.7.2.1 Consumer/wellness genomics market, by test type, 2014 – 2025 (USD Million)
8.7.2.2 Consumer/wellness genomics market, by application, 2014 – 2025 (USD Million)
8.7.2.3 Consumer/wellness genomics market, by setting type, 2014 – 2025 (USD Million)
Chapter 9 Competitive Landscape
9.1 Strategy framework
9.2 Market participation categorization
9.2.1 Key Initiatives
9.3 Company Profiles
9.3.1 F. Hoffmann-La Roche Ltd.
9.3.1.1 Company overview
9.3.1.1.1 454 Life Sciences Corporation
9.3.1.2 Financial performance
9.3.1.3 Product benchmarking
9.3.1.4 Strategic initiatives
9.3.2 Abbott Laboratories
9.3.2.1 Company overview
9.3.2.2 Financial performance
9.3.2.3 Product benchmarking
9.3.2.4 Strategic initiatives
9.3.3 Thermo Fisher Scientific, Inc.
9.3.3.1 Company overview
9.3.3.1.1 Affymetrix, Inc.
9.3.3.1.2 Applied Biosystems
9.3.3.2 Financial performance
9.3.3.2.1 Financial performance (Affymetrix)
9.3.3.3 Product benchmarking
9.3.3.4 Strategic initiatives
9.3.4 Agilent Technologies, Inc.
9.3.4.1 Company overview
9.3.4.2 Financial performance
9.3.4.3 Product benchmarking
9.3.4.4 Strategic initiatives
9.3.5 BGI
9.3.5.1 Company overview
9.3.5.1.1 Complete Genomics Incorporated
9.3.5.2 Financial performance
9.3.5.3 Product benchmarking
9.3.5.4 Strategic initiatives
9.3.6 Bio-Rad Laboratories, Inc.
9.3.6.1 Company overview
9.3.6.1.1 GnuBIO, Inc.
9.3.6.2 Financial performance
9.3.6.3 Product benchmarking
9.3.6.4 Strategic initiatives
9.3.7 Illumina, Inc.
9.3.7.1 Company overview
9.3.7.2 Financial performance
9.3.7.3 Product benchmarking
9.3.7.4 Strategic initiatives
9.3.8 QIAGEN
9.3.8.1 Company overview
9.3.8.2 Financial performance
9.3.8.3 Product benchmarking
9.3.8.4 Strategic initiatives
9.3.9 Positive Biosciences, Ltd.
9.3.9.1 Company overview
9.3.9.2 Financial performance
9.3.9.3 Product benchmarking
9.3.9.4 Strategic initiatives
9.3.10 Myriad Genetics, Inc.
9.3.10.1 Company overview
9.3.10.2 Financial performance
9.3.10.3 Product benchmarking
9.3.10.4 Strategic initiatives
9.3.11 Siemens
9.3.11.1 Company overview
9.3.11.2 Financial performance
9.3.11.3 Product benchmarking
9.3.11.4 Strategic initiatives
9.3.12 Pathway Genomics
9.3.12.1 Company overview
9.3.12.2 Financial performance
9.3.12.3 Product benchmarking
9.3.12.4 Strategic initiatives
9.3.13 Cooper Surgical, Inc.
9.3.13.1 Company overview
9.3.13.1.1 Genesis Genetics
9.3.13.1.2 Reprogenetics
9.3.13.1.3 Financial performance
9.3.13.1.4 Financial performance
9.3.13.2 Product benchmarking
9.3.13.3 Strategic initiatives
9.3.14 Konica Minolta, Inc. (Ambry Genetics Corporation)
9.3.14.1 Company overview
9.3.14.2 Financial performance
9.3.14.3 Product benchmarking
9.3.14.4 Strategic initiatives
9.3.15 23andMe, Inc.
9.3.15.1 Company overview
9.3.15.2 Financial performance
9.3.15.3 Product benchmarking
9.3.15.4 Strategic initiatives
9.3.16 Danaher Corporation
9.3.16.1 Company overview
9.3.16.1.1 Beckman Coulter, Inc.
9.3.16.2 Financial performance
9.3.16.3 Product benchmarking
9.3.16.4 Strategic initiatives
9.3.17 Cepheid
9.3.17.1 Company overview
9.3.17.2 Financial performance
9.3.17.3 Product benchmarking
9.3.17.4 Strategic initiatives
9.3.18 Hologic, Inc. (Gen-Probe Incorporated)
9.3.18.1 Company overview
9.3.18.2 Financial performance
9.3.18.3 Product benchmarking
9.3.18.4 Strategic initiatives
9.3.19 ARUP Laboratories
9.3.19.1 Company overview
9.3.19.2 Financial performance
9.3.19.3 Product benchmarking
9.3.19.4 Strategic initiatives
9.3.20 GUARDANT HEALTH, INC.
9.3.20.1 Company overview
9.3.20.2 Financial performance
9.3.20.3 Product benchmarking
.3.20.4 Strategic initiatives
9.3.21 Advanced Genomic Solutions (AGS) Ltd.
9.3.21.1 Company overview
9.3.21.2 Financial performance
9.3.21.3 Product benchmarking
9.3.21.4 Strategic initiatives
9.3.22 EasyDNA
9.3.22.1 Company overview
9.3.22.2 Financial performance
9.3.22.3 Product benchmarking
9.3.22.4 Strategic initiatives
9.3.23 Color Genomics, Inc.
9.3.23.1 Company overview
9.3.23.2 Financial performance
9.3.23.3 Product benchmarking
9.3.23.4 Strategic initiatives
9.3.24 Myriad Genetics, Inc. (Counsyl, Inc.)
9.3.24.1 Company overview
9.3.24.2 Financial performance
9.3.24.3 Product benchmarking
9.3.24.4 Strategic initiatives
9.3.25 Gene by Gene
9.3.25.1 Company overview
9.3.25.2 Financial performance
9.3.25.3 Product benchmarking
9.3.25.4 Strategic initiatives
9.3.26 Mapmygenome
9.3.26.1 Company overview
9.3.26.2 Financial performance
9.3.26.3 Product benchmarking
9.3.26.4 Strategic initiatives
9.3.27 Orig3n (Interleukin Genetics Inc.)
9.3.27.1 Company overview
9.3.27.2 Financial performance
9.3.27.3 Product benchmarking
9.3.27.4 Strategic initiatives
9.3.28 Laboratory Corporation of America Holdings
9.3.28.1 Company overview
9.3.28.2 Financial performance
9.3.28.3 Product benchmarking
9.3.28.4 Strategic initiatives
9.3.29 Quest Diagnostics Incorporated
9.3.29.1 Company overview
9.3.29.1.1 Sonora Quest Laboratories
9.3.29.2 Financial performance
9.3.29.2.1 Financial performance
9.3.29.3 Product benchmarking
9.3.29.4 Strategic initiatives
9.3.30 Xcode Life
9.3.30.1 Company overview
9.3.30.2 Financial performance
9.3.30.3 Product benchmarking
9.3.30.4 Strategic initiatives
9.3.31 Amgen, Inc.
9.3.31.1 Company overview
9.3.31.1.1 deCODE genetics
9.3.31.2 Financial performance (Amgen, Inc.)
9.3.31.3 Product benchmarking
9.3.31.4 Strategic initiatives
9.4 List of Companies

List of Tables

TABLE 1 Funding raised through U.S. government for precision medicine (USD Million)
TABLE 2 Healthcare expenditure levels, 2018
TABLE 3 North America predictive genetic testing & consumer/wellness genomics market, by test type, 2014 - 2025 (USD Million)
TABLE 4 North America predictive testing market, by test, 2014 - 2025 (USD Million)
TABLE 5 North America wellness genetics market, by application, 2014 - 2025 (USD Million)
TABLE 6 North America predictive genetic testing & consumer genomics market, by application, 2014 - 2025 (USD Million)
TABLE 7 North America predictive genetic testing & consumer genomics market, by setting type, 2014 - 2025 (USD Million)
TABLE 8 U.S. predictive genetic testing & consumer/wellness genomics market, by test type, 2014 - 2025 (USD Million)
TABLE 9 U.S. predictive testing market, by test, 2014 - 2025 (USD Million)
TABLE 10 U.S. wellness genetics market, by application, 2014 - 2025 (USD Million)
TABLE 11 U.S. predictive genetic testing & consumer genomics market, by application, 2014 - 2025 (USD Million)
TABLE 12 U.S. predictive genetic testing & consumer genomics market, by setting type, 2014 - 2025 (USD Million)
TABLE 13 Canada predictive genetic testing & consumer/wellness genomics market, by test type, 2014 - 2025 (USD Million)
TABLE 14 Canada predictive testing market, by test, 2014 - 2025 (USD Million)
TABLE 15 Canada wellness genetics market, by application, 2014 - 2025 (USD Million)
TABLE 16 Canada predictive genetic testing & consumer genomics market, by application, 2014 - 2025 (USD Million)
TABLE 17 Canada predictive genetic testing & consumer genomics market, by setting type, 2014 - 2025 (USD Million)
TABLE 18 Europe predictive genetic testing & consumer/wellness genomics market, by test type, 2014 - 2025 (USD Million)
TABLE 19 Europe predictive testing market, by test, 2014 - 2025 (USD Million)
TABLE 20 Europe wellness genetics market, by application, 2014 - 2025 (USD Million)
TABLE 21 Europe predictive genetic testing & consumer genomics market, by application, 2014 - 2025 (USD Million)
TABLE 22 Europe predictive genetic testing & consumer genomics market, by setting type, 2014 - 2025 (USD Million)
TABLE 23 Germany predictive genetic testing & consumer/wellness genomics market, by test type, 2014 - 2025 (USD Million)
TABLE 24 Germany predictive testing market, by test, 2014 - 2025 (USD Million)
TABLE 25 Germany wellness genetics market, by application, 2014 - 2025 (USD Million)
TABLE 26 Germany predictive genetic testing & consumer genomics market, by application, 2014 - 2025 (USD Million)
TABLE 27 Germany predictive genetic testing & consumer genomics market, by setting type, 2014 - 2025 (USD Million)
TABLE 28 U.K. predictive genetic testing & consumer/wellness genomics market, by test type, 2014 - 2025 (USD Million)
TABLE 29 U.K. predictive testing market, by test, 2014 - 2025 (USD Million)
TABLE 30 U.K. wellness genetics market, by application, 2014 - 2025 (USD Million)
TABLE 31 U.K. predictive genetic testing & consumer genomics market, by application, 2014 - 2025 (USD Million)
TABLE 32 U.K. predictive genetic testing & consumer genomics market, by setting type, 2014 - 2025 (USD Million)
TABLE 33 Asia Pacific predictive genetic testing & consumer/wellness genomics market, by test type, 2014 - 2025 (USD Million)
TABLE 34 Asia Pacific predictive testing market, by test, 2014 - 2025 (USD Million)
TABLE 35 Asia Pacific wellness genetics market, by application, 2014 - 2025 (USD Million)
TABLE 36 Asia Pacific predictive genetic testing & consumer genomics market, by application, 2014 - 2025 (USD Million)
TABLE 37 Asia Pacific predictive genetic testing & consumer genomics market, by setting type, 2014 - 2025 (USD Million)
TABLE 38 Japan predictive genetic testing & consumer/wellness genomics market, by test type, 2014 - 2025 (USD Million)
TABLE 39 Japan predictive testing market, by test, 2014 - 2025 (USD Million)
TABLE 40 Japan wellness genetics market, by application, 2014 - 2025 (USD Million)
TABLE 41 Japan predictive genetic testing & consumer genomics market, by application, 2014 - 2025 (USD Million)
TABLE 42 Japan predictive genetic testing & consumer genomics market, by setting type, 2014 - 2025 (USD Million)
TABLE 43 Availability of specific services in China market of predictive genetic testing & consumer/wellness genomics
TABLE 44 China predictive genetic testing & consumer/wellness genomics market, by test type, 2014 - 2025 (USD Million)
TABLE 45 China predictive testing market, by test, 2014 - 2025 (USD Million)
TABLE 46 China wellness genetics market, by application, 2014 - 2025 (USD Million)
TABLE 47 China predictive genetic testing & consumer genomics market, by application, 2014 - 2025 (USD Million)
TABLE 48 China predictive genetic testing & consumer genomics market, by setting type, 2014 - 2025 (USD Million)
TABLE 49 Australia predictive genetic testing & consumer/wellness genomics market, by test type, 2014 - 2025 (USD Million)
TABLE 50 Australia predictive testing market, by test, 2014 - 2025 (USD Million)
TABLE 51 Australia wellness genetics market, by application, 2014 - 2025 (USD Million)
TABLE 52 Australia predictive genetic testing & consumer genomics market, by application, 2014 - 2025 (USD Million)
TABLE 53 Australia predictive genetic testing & consumer genomics market, by setting type, 2014 - 2025 (USD Million)
TABLE 54 India predictive genetic testing & consumer/wellness genomics market, by test type, 2014 - 2025 (USD Million)
TABLE 55 India predictive testing market, by test, 2014 - 2025 (USD Million)
TABLE 56 India wellness genetics market, by application, 2014 - 2025 (USD Million)
TABLE 57 India predictive genetic testing & consumer genomics market, by application, 2014 - 2025 (USD Million)
TABLE 58 India predictive genetic testing & consumer genomics market, by setting type, 2014 - 2025 (USD Million)
TABLE 59 Singapore predictive genetic testing & consumer/wellness genomics market, by test type, 2014 - 2025 (USD Million)
TABLE 60 Singapore predictive testing market, by test, 2014 - 2025 (USD Million)
TABLE 61 Singapore wellness genetics market, by application, 2014 - 2025 (USD Million)
TABLE 62 Singapore predictive genetic testing & consumer genomics market, by application, 2014 - 2025 (USD Million)
TABLE 63 Singapore predictive genetic testing & consumer genomics market, by setting type, 2014 - 2025 (USD Million)
TABLE 64 Latin America predictive genetic testing & consumer/wellness genomics market, by test type, 2014 - 2025 (USD Million)
TABLE 65 Latin America predictive testing market, by test, 2014 - 2025 (USD Million)
TABLE 66 Latin America wellness genetics market, by application, 2014 - 2025 (USD Million)
TABLE 67 Latin America predictive genetic testing & consumer genomics market, by application, 2014 - 2025 (USD Million)
TABLE 68 Latin America predictive genetic testing & consumer genomics market, by setting type, 2014 - 2025 (USD Million)
TABLE 69 Brazil predictive genetic testing & consumer/wellness genomics market, by test type, 2014 - 2025 (USD Million)
TABLE 70 Brazil predictive testing market, by test, 2014 - 2025 (USD Million)
TABLE 71 Brazil wellness genetics market, by application, 2014 - 2025 (USD Million)
TABLE 72 Brazil predictive genetic testing & consumer genomics market, by application, 2014 - 2025 (USD Million)
TABLE 73 Brazil predictive genetic testing & consumer genomics market, by setting type, 2014 - 2025 (USD Million)
TABLE 74 MEA predictive genetic testing & consumer/wellness genomics market, by test type, 2014 - 2025 (USD Million)
TABLE 75 MEA predictive testing market, by test, 2014 - 2025 (USD Million)
TABLE 76 MEA wellness genetics market, by application, 2014 - 2025 (USD Million)
TABLE 77 MEA predictive genetic testing & consumer genomics market, by application, 2014 - 2025 (USD Million)
TABLE 78 Brazil predictive genetic testing & consumer genomics market, by setting type, 2014 - 2025 (USD Million)
TABLE 79 MEA predictive genetic testing & consumer/wellness genomics market, by test type, 2014 - 2025 (USD Million)
TABLE 80 South Africa predictive testing market, by test, 2014 - 2025 (USD Million)
TABLE 81 South Africa wellness genetics market, by application, 2014 - 2025 (USD Million)
TABLE 82 South Africa predictive genetic testing & consumer genomics market, by application, 2014 - 2025 (USD Million)
TABLE 83 South Africa predictive genetic testing & consumer genomics market, by setting type, 2014 - 2025 (USD Million)

【レポートのキーワード】

予測遺伝子検査&消費者/ウェルネスゲノミクス、予測検査、消費者ゲノミクス、ウェルネス遺伝学、乳がんおよび卵巣がんのスクリーニング、心臓血管のスクリーニング、糖尿病のスクリーニングおよびモニタリング、結腸がんのスクリーニング、パーキンソニズム/アルツハイマー病、泌尿器科スクリーニング/前立腺がん、整形外科および筋骨格のスクリーニング、その他のがんのスクリーニング、その他の疾患のスクリーニング、DTC、プロ

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[予測遺伝子検査&消費者/ウェルネスゲノミクスの世界市場:予測検査、消費者ゲノミクス、ウェルネス遺伝学]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆